NinePointTwo Capital »

Iovance Biotherapeutics shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $231k 33k 7.01
2022-12-31 $255k 40k 6.38

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors
Two Sigma Investments

View all funds holding Iovance Biotherapeutics